Literature DB >> 31213463

Medical Conditions and Modifiable Risk Factors for Myelodysplastic Syndrome: A Systematic Review.

Marina R Sweeney1, Katie M Applebaum2, Hannah Arem1, Barbara H Braffett1,3, Jenny N Poynter4, Kim Robien5,6.   

Abstract

BACKGROUND: The aim of this systematic review was to evaluate medical conditions and modifiable risk factors for myelodysplastic syndromes (MDS) using the 2001 or 2008 World Health Organization (WHO) diagnostic criteria.
METHODS: PubMed, MEDLINE, and Scopus databases were searched for studies published between January 2001 and August 2017. Study characteristics and findings were abstracted for each article.
RESULTS: Thirteen articles (4 cohort, 9 case-control) met the inclusion criteria. Smoking and alcohol use were each evaluated as potential MDS risk factors in four studies. Body mass index and anemia were each evaluated in two studies. Other potential risk factors evaluated in single studies included physical activity, dietary intake (tea, isoflavones, meat, fruit, or vegetables), history of allergies, autoimmune disorders and community-acquired infections, and use of antituberculosis drugs, traditional Chinese medicines, or hair dyes.
CONCLUSIONS: Higher BMI, smoking, a history of autoimmune disorders, community-acquired infections, history of anemia, and use of antituberculosis drugs were associated with higher risk of MDS. Vigorous physical activity and tea and dietary isoflavone intake were associated with lower MDS risk. These findings suggest no association between the other factors and risk of MDS. IMPACT: Research on risk factors for MDS is limited, and further research in larger studies is needed. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31213463     DOI: 10.1158/1055-9965.EPI-19-0106

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  4 in total

1.  The association between non-steroidal anti-inflammatory drugs (NSAIDs) and myelodysplastic syndromes in the Adults in Minnesota with Myelodysplastic Syndromes (AIMMS) Study.

Authors:  Aubrey K Hubbard; Michaela Richardson; Michelle A Rosesler; Adina Cioc; Phuong L Nguyen; Erica Warlick; Jenny N Poynter
Journal:  Leuk Lymphoma       Date:  2021-01-08

2.  Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries.

Authors:  Marta Solans; Arantza Sanvisens; Alberto Ameijide; Susana Merino; Dolores Rojas; Araceli Alemán; Emilia Banqueri; Matilde Chico; Ana Isabel Marcos; Visitación de Castro; Leire Gil; Arantza López de Munain; Montse Puigdemont; Maria-José Sánchez; Josefina Perucha; Patricia Ruiz-Armengol; Mª Dolores Chirlaque; Marcela Guevara; Marià Carulla; Rafael Marcos-Gragera
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

3.  Environmental and occupational determinants of myelodysplastic syndrome: A case-control study from Pakistan.

Authors:  Nida Anwar; Aisha Arshad; Naveena Fatima; Sumaira Shaheen; Sumera Bukhari; Tahir Shamsi
Journal:  Cancer Rep (Hoboken)       Date:  2021-10-27

4.  Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).

Authors:  Rina Yarosh; Michelle A Roesler; Thomas Murray; Adina Cioc; Betsy Hirsch; Phuong Nguyen; Erica Warlick; Jenny N Poynter
Journal:  Cancer Causes Control       Date:  2021-01-04       Impact factor: 2.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.